Literature DB >> 24506266

A DFNA5 mutation identified in Japanese families with autosomal dominant hereditary hearing loss.

Ayako Nishio1, Yoshihiro Noguchi, Tatsuya Sato, Taeko K Naruse, Akinori Kimura, Akira Takagi, Ken Kitamura.   

Abstract

Mutations in DFNA5 lead to autosomal dominant nonsyndromic hereditary hearing loss (NSHHL). To date, four different mutations in DFNA5 have been reported to cause hearing loss. A 3 bp deletion mutation (c.991-15_991-13del) was identified in Chinese and Korean families with autosomal dominant NSHHL, which suggested that the 3 bp deletion mutation was derived from a single origin. In the present study, we performed genetic screening of mutations in the interval between intron 6 and exon 9 of DFNA5 in 65 Japanese patients with autosomal dominant NSHHL and identified the c.991-15_991-13del mutation in two patients. Furthermore, we compared the DFNA5-linked haplotypes consisting of intragenic SNPs between the reported Chinese and Korean families and found that the Japanese patients showed a shared region spanning 41,874 bp. This is the first report of DFNA5 mutations in Japanese patients with autosomal dominant NSHHL, supporting the suggestion that the 3 bp deletion mutation occurred in their ancestors.
© 2014 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  DFNA5; autosomal dominant; hearing loss; hereditary; nystagmus; sensorineural

Mesh:

Substances:

Year:  2014        PMID: 24506266     DOI: 10.1111/ahg.12053

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  11 in total

1.  Exonic mutations and exon skipping: Lessons learned from DFNA5.

Authors:  Kevin T Booth; Hela Azaiez; Kimia Kahrizi; Donghong Wang; Yuzhou Zhang; Kathy Frees; Carla Nishimura; Hossein Najmabadi; Richard J Smith
Journal:  Hum Mutat       Date:  2018-01-11       Impact factor: 4.878

Review 2.  Modulation of Autoimmune and Autoinflammatory Diseases by Gasdermins.

Authors:  Fang Liang; Weixiao Qin; Yilan Zeng; Dan Wang
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  Further evidence for "gain-of-function" mechanism of DFNA5 related hearing loss.

Authors:  Hongyang Wang; Jing Guan; Liping Guan; Ju Yang; Kaiwen Wu; Qiongfen Lin; Wenping Xiong; Lan Lan; Cui Zhao; Linyi Xie; Lan Yu; Lidong Zhao; Dayong Wang; Qiuju Wang
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

4.  Role of DFNA5 in hearing loss and cancer - a comment on Rakusic et al.

Authors:  Lieselot Croes; Ken Op de Beeck; Guy Van Camp
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

5.  Associations of genetic variations in EYA4, GRHL2 and DFNA5 with noise-induced hearing loss in Chinese population: a case- control study.

Authors:  Xuhui Zhang; Yi Liu; Lei Zhang; Zhangping Yang; Luoxian Yang; Xuchu Wang; CaiXia Jiang; Qiang Wang; Yuyong Xia; Yanjuan Chen; Ou Wu; Yimin Zhu
Journal:  Environ Health       Date:  2015-09-24       Impact factor: 5.984

6.  The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways.

Authors:  Sofie Van Rossom; Ken Op de Beeck; Vesna Hristovska; Joris Winderickx; Guy Van Camp
Journal:  Front Cell Neurosci       Date:  2015-07-16       Impact factor: 5.505

7.  IVS8+1 DelG, a Novel Splice Site Mutation Causing DFNA5 Deafness in a Chinese Family.

Authors:  Mei-Na Li-Yang; Xiao-Fei Shen; Qin-Jun Wei; Jun Yao; Ya-Jie Lu; Xin Cao; Guang-Qian Xing
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

8.  DFNA5 (GSDME) c.991-15_991-13delTTC: Founder Mutation or Mutational Hotspot?

Authors:  Kevin T Booth; Hela Azaiez; Richard J H Smith
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

Review 9.  Gasdermins in Apoptosis: New players in an Old Game.

Authors:  Corey Rogers; Emad S Alnemri
Journal:  Yale J Biol Med       Date:  2019-12-20

Review 10.  Channelling inflammation: gasdermins in physiology and disease.

Authors:  Xing Liu; Shiyu Xia; Zhibin Zhang; Hao Wu; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2021-03-10       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.